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ABSTRACT: The reactions of allenes with frustrated (or
cooperative) Lewis acid/base pairs result in the 1,4-addition of
the base pair to the allene. The reactions of allenyl ketones and
esters just in the presence of the strong Lewis acid B(C6F5)3
aﬀord the selective formation of the 1,2-carboboration
products. In both cases the Lewis acid activates the allene to
either a C6F5 migration or nucleophilic attack by the Lewis
base. In addition to the 1,2-carboboration pathway, which can
be viewed as being triggered by activation of the ketone (σ-
activation), in the case of allenyl esters the corresponding
cyclization products are observed in the presence of water.
■ INTRODUCTION
The chemistry of frustrated Lewis pairs (FLPs) has exploded
since their ﬁrst report in 2006.1 The combination of a Lewis
acid and a Lewis base where steric hindrance impedes classical
Lewis acid/base adduct formation constitutes an FLP. Owing
to the unquenched Lewis acidity and basicity, such systems
display unique reactivity and are capable of activating small
molecules such as H2, CO2, N2O, SO2, alkenes, and alkynes,
inter alia.2 In the case of H2 activation, FLPs have been
employed in metal-free hydrogenation catalysis for the
reduction of a variety of unsaturated substrates,2,3 including
enantioselective hydrogenations.4 FLPs have also been shown
to eﬀect 1,2-additions to both alkynes and alkenes. In these
cases, the Lewis base (e.g., amines, phosphines, thiols, or
amides) acts as the nucleophile and the Lewis acid (usually a
borane or alane) as the electrophile (Scheme 1, path I).5 This
has also been extended to 1,4-addition processes in the case of
1,3-dienes,6 1,3-enynes, and 1,3-diynes.7 In this context, we
have implemented the strong Lewis acid B(C6F5)3 to activate
the alkyne moiety, thus promoting intramolecular attack by
nucleophilic amide or ester functionalities.8,9 In the case of
terminal propargyl esters intramolecular cyclization onto the π-
activated alkyne followed by a subsequent C6F5 shift from
boron to carbon (1,1-carboboration) leads to cyclic allyl boron
reagents, which can then undergo a rearrangement reaction to
yield the formal 1,3-carboboration products (Scheme 1, path
II).9 While π-Lewis acidic transition metals such as gold can
interact strongly with π-bonds,10 the corresponding boron−π-
bond complex has never been isolated, although weak van der
Waals interactions have been detected.11 In FLP chemistry,
computational studies have shown that an “encounter complex”
forms between the Lewis acid (B(C6F5)3), the Lewis base
(tBu3P), and ethylene in which both the Lewis acid and base
components of the FLP interact simultaneously with the
alkene.12 In these calculations, the addition reaction was shown
to be asynchronous, with the C−B bond forming slightly before
P−C bond formation. However, in other cases it was calculated
that the borane initially associated with ethylene, which was
then followed by 1,2-FLP addition.13
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Carboboration reactions of alkynes result in the breaking of
the C−B bond in the R3B starting material and the formation of
both R−C and C−BR2 bonds14,15 providing a versatile
synthetic method to substituted alkenylboranes. Such species
have found applications in a variety of organic transformations,
including cross-coupling reactions.16 Typically, transition-
metal-based catalysts such as those with copper, palladium,
and nickel have been utilized to eﬀect carboboration
reactions,17 although Ohmiya and Sawamura et al. recently
reported an elegant approach to aﬀord 1,2-trans-carboboration
products using phosphine organocatalysis with alkynoates
(Scheme 2, path I).18 Earlier reports of metal-free, noncatalyzed
carboboration reactions described as the “Wrackmeyer
reaction” involved “activated” alkynes such as acetylides derived
from the heavier group 14 elements or terminal metal alkynyl
species which reacted in the presence of trialkylboranes.14,19 In
these cases, a 1,2-shift reaction leads to 1,1-carboboration
products which are postulated to proceed through the
formation of alkynylborates (Scheme 2, path II). In the past
few years, the Erker group extended this methodology to
“normal” terminal and internal alkynes utilizing the strong
Lewis acids B(C6F5)3 and RB(C6F5)2 to generate alkenylbor-
anes in a 1,1-carboboration reaction (Scheme 2, path III)14,15 in
contrast to 1,2-hydroborations.20 However, recent work by
Ingleson and Bourissou has described borenium systems that
eﬀect metal-free syn-1,2-carboborations: for example, in the
selective transfer of phenyl and thienyl groups from the
borenium system to the alkyne (Scheme 2, path IV).21
Herein, we report the reactions of (frustrated) Lewis acid/
base pairs with allenes and also show that in the absence of the
Lewis base metal-free regioselective 1,2-carboboration reactions
of allenes take place using the strong Lewis acid B(C6F5)3.
Interestingly, Alcarazo et al. studied the FLP-catalyzed
hydrogenation of electron-deﬁcient allenes, although the
addition reactions of FLPs in the absence of hydrogen were
not described.22
■ RESULTS AND DISCUSSION
Reactivity of Allenyl Ketones toward Cooperative
Lewis Pairs. We initially investigated the reactions of Lewis
acid/base pairs with allenes in the anticipation that the Lewis
acid and base could add across the terminal alkene unit of the
allene similarly to that observed for the 1,2-addition of FLPs
with alkenes and alkynes (Scheme 1, path I).5 The allene
starting materials 1a−e bearing an electron-withdrawing ketone
functionality were synthesized according to standard literature
protocols, involving homopropargylation mediated by the in
situ generated organozinc compounds followed by Dess−
Martin periodinane oxidation (see the Supporting Informa-
tion). The allenyl ketones 1a−e were subsequently reacted with
the Lewis acid B(C6F3)3 and a tertiary phosphine (P(o-tol)3,
P(m-FC6H4)3, P(p-OMeC6H4)3, PBn3) in a 1:1:1 stoichio-
metric ratio. The in situ NMR-scale reaction of 1a−e with the
Lewis acid/base combination in CDCl3 resulted in an
immediate color change to give orange or red solutions in all
cases. The reactions were extremely rapid and clean, as
observed by NMR (1H, 19F, 11B, 13C, 31P) spectroscopy,
yielding the products 2a−k (Scheme 3) quantitatively by NMR
spectroscopy under ambient conditions, although the isolated
yields were sometimes lower. The 11B NMR spectra were all
very similar for compounds 2, displaying a resonance between
Scheme 2. Catalyzed and Noncatalyzed Carboboration
Reactions
Scheme 3. Reactions of Allenyl Ketones 1 with FLPs To Give
2a
aIsolated yields are indicated.
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−3.5 and −4.0 ppm. With the exception of 2f,g, the 19F spectra
revealed three signals in a 2:2:1 ratio due to the ortho (δ
−132.7 to −133.3 ppm), meta (δ −164.9 to −165.9 ppm), and
para (δ −160.1 to −161.2 ppm) ﬂuorine atoms on the
pentaﬂuorophenyl rings. For 2f,g, an additional signal of
intensity 1 was also observed at δ −105.5 and −105.2 ppm,
respectively, due to the m-ﬂuorine atoms on the phosphine.
The 31P{1H} NMR spectra showed a signal due to the
phosphorus environment which was dependent upon the
phosphine employed in the reaction: P(o-tol)3 (δ 22.8−23.6
ppm (2b−e)), P(m-FC6H5)3 (δ 22.7−22.8 ppm (2f,g)), P(p-
OMeC6H5)3 (δ 21.7 ppm (2h,i)), PBn3 (δ 25.0−25.2 ppm
(2j,k)).
In the case of 2a−c,f,j,k crystals could be obtained from the
CDCl3 solution. In addition, the stoichiometric reaction of 1b
with B(C6F5)3 and P(o-tol)3 on a preparative scale in toluene
followed by recrystallization from hexane/toluene yielded a
small crop of colorless crystals. Single-crystal X-ray diﬀraction
of the crystals 2a−c,f,j,k conﬁrmed the identity of these species
as the products arising from the addition of the Lewis acid/base
pairs to the allene oxygen and β-carbon atom of the allene
(Figures 1 and 2).
The metric parameters for 2a−c,f,j,k are very similar (Table
1). Although the two double bonds C1C2 and C3C4 are
conjugated, in the solid state the O−C1−C2−C3-C4 system is
not completely planar with the C3−C4 bond twisting out of the
O−C1−C2 plane, consistent with reduced delocalization of
electron density across the π-system. The torsion angles
between the C1C2C3 plane and the C2C3C4 plane are
29.5(3)° (2a), 23.8(5)° (2b), 23.8(3)° (2c), 14.2(4)° (2f),
22.5(3)° (2j), and 21.9(2)° (2k). This twisting eﬀect
presumably arises through crystal packing. Additionally, the
aryl ring attached to C1 also rotates out of the O−C1−C2 plane,
presumably also a result of steric hindrance. In all cases, it can
be seen from the crystal structure that the two alkenes adopt an
s-cis conﬁguration.
The Lewis acid/base addition reaction is thought to be
initiated by adduct formation between the strong Lewis acid
and the ketone oxygen atom through a σ-activation mode. Our
previous studies on the reactivity of B(C6F5)3 with related
propargyl amides and esters revealed that adduct formation
occurred immediately, albeit reversibly, under ambient
conditions.8,9 This O-coordination has the eﬀect of removing
electron density from the β-position of the allene, resulting in
the buildup of a large partial positive charge at this carbon
atom. This renders the β-position susceptible to nucleophilic
attack (conjugate addition) from the phosphine resulting in
2a−k (Scheme 4). The independent reaction of phosphines
with the allenes in the absence of B(C6F5)3 showed no reaction,
as evidenced by the 31P and 31P{1H} NMR spectra, which only
show free phosphine. This does not rule out addition of the
phosphine to the allene which may be rapid and reversible at
room temperature but rather suggests that B(C6F5)3 is
necessary for the isolation of the addition product.23
Reactivity of Allenyl Ketones and Esters toward
B(C6F5)3. The study of the intrinsic reactivity of allene
substrates with B(C6F5)3 in the absence of added Lewis base
was subsequently investigated. The 1:1 stoichiometric reactions
of the allenes 1a−e with B(C6F3)3 proceeded very rapidly at
room temperature (<30 min) to give new compounds in which
the B(C6F5)3 underwent a regioselective 1,2-carboboration
reaction with the terminal CC moiety of the allene.
Interestingly, Alcarazo et al. observed in the case of electron
-rich allenes nucleophilic attack of the central carbon atom onto
B(C6F5)3 but did not observe any carboboration due to the
enhanced stability of the allene−borane products generated.22
Products 3a−e were identiﬁed as α,β-unsaturated ketones with
a pentaﬂuorophenyl group at the β-position (Scheme 5). The
reactions were selective, giving products in which the double-
bond conﬁguration is exclusively E. The products were fully
characterized by multinuclear NMR, mass spectrometry, and/or
elemental analysis. In the 11B NMR spectrum a single broad
peak observed around 0 ppm is attributed to coordination of
the borane to the ketone oxygen atom, yielding an intra-
Figure 1. Solid-state molecular structures of 2a−c,f (from top to
bottom): C, black; O, red; B, yellow-green; F, pink; P, orange.
Hydrogen atoms are omitted for clarity.
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molecular chelate analogous to those observed previously for
related allyl boron products.9 In the 19F NMR spectrum six
peaks are observed for the two diﬀerent C6F5 rings in a 2:1
ratio.
Crystals of 3a,b suitable for X-ray diﬀraction could be
obtained by dissolving the solid in a few drops of toluene with
the addition of 1 drop of hexane and maintaining the
temperature at −40 °C. X-ray diﬀraction analysis conﬁrmed
the products as being α,β-unsaturated ketones in which a C6F5
group has been transferred to the β-position of the allene and
the boron transferred to the γ-position in a net 1,2-
carboboration reaction (Figure 3). The structural parameters
for the C4OB heterocycle in the products 3a,b are the same
within error and are included in Table 2.
Further proof of the identity of these compounds was
obtained from the reactions of the allenyl esters 4a,b with
B(C6F3)3 (Scheme 6). These allenes contain ester function-
alities rather than ketones as in the allenes 1 and could be easily
prepared in one step in a modiﬁed Wittig reaction with the
corresponding acyl chlorides (see the Supporting Information).
Unlike the reactions of 1 with B(C6F5)3, which were rapid at
room temperature, the 1:1 reactions of the allenes 4a,b with
B(C6F5)3 were inconclusive by in situ NMR in CDCl3.
However, the preparative reaction in CH2Cl2 showed evidence
of the 1,2-carboboration products 5a,b, respectively, which
were formed as a racemic mixture (Scheme 6). Slow
evaporation of volatiles from a hexane/CH2Cl2 (5a) or
hexane/toluene (5b) solution aﬀorded a very small crop of
colorless crystals suitable for single-crystal X-ray diﬀraction
(Figure 4).
In the case of 5a,b, the structural analysis conﬁrmed that
B(C6F5)3 had added in a 1,2-fashion across the π-bond of the
allene distant from the ester group, with one of the C6F5 groups
being transferred from boron to carbon. These reactions are
Figure 2. Solid-state molecular structures of 2j,k (from top to
bottom): C, black; O, red; B, yellow-green; F, pink; P, orange; Cl,
aquamarine. Hydrogen atoms are omitted for clarity.
Table 1. Experimental Bond Lengths (Å) in 2a−c,f,j,k
bond 2a 2b 2c 2f 2j 2k
C1−C2 1.347(2) 1.352(4) 1.356(2) 1.356(3) 1.359(3) 1.353(2)
C2−C3 1.465(3) 1.468(4) 1.464(2) 1.460(3) 1.463(3) 1.466(2)
C3−C4 1.337(3) 1.332(5) 1.340(2) 1.339(3) 1.337(3) 1.335(2)
C1−O 1.339(2) 1.334(4) 1.336(2) 1.337(3) 1.339(2) 1.335(2)
O−B 1.495(3) 1.493(4) 1.489(2) 1.499(3) 1.490(2) 1.493(2)
C3−P 1.818(2) 1.825(3) 1.811(1) 1.811(2) 1.800(2) 1.804(1)
Scheme 4. Reactions of Allenes with Lewis Acid/Base Pairs
Scheme 5. Reactions of B(C6F5)3 with Allenes 1a−e
a
aIsolated yields are indicated.
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regioselective, with the C6F5 group being transferred to the β-
position of the allene and the B(C6F5)2 group being installed at
the γ-position. The reactions were also selective, giving the E
isomer, which is presumably a result of the intramolecular
nature of the reaction and due to the formation of a stable six-
membered chelate product via intramolecular coordination of
the ester oxygen to the Lewis-acidic boron center. In both cases
the compounds showed a broad peak in the 11B NMR spectrum
at 4.2 ppm (5a) and 4.5 ppm (5b) typical for boron adducts.
The structural parameters are summarized in Table 2.
However, the reaction outcome was altered by traces of
water in the mixture of allenyl ester 4c and B(C6F5)3. In this
case the corresponding γ-lactone cyclization product (6c) in
which the lactone carbonyl oxygen atom coordinates to
B(C6F5)3 was obtained in 56% yield (Scheme 7). This
compound formulation was veriﬁed by single-crystal X-ray
diﬀraction (Figure 5) and resembles compounds typically
obtained in catalytic reactions with π-Lewis acidic transition
metals such as gold and palladium.24,25 Further attempts to
trigger these cyclization reactions in a catalytic fashion are
ongoing but are challenging, as complete suppression of the
1,2-carboboration pathway is required in order to promote
lactone formation.
Figure 3. Solid-state molecular structures of 3a (top) and 3b (bottom,
toluene solvent omitted for clarity): C, black; O, red; B, yellow-green;
F, pink. Hydrogen atoms are omitted for clarity.
Table 2. Experimental Bond Lengths in 3a,b and 5a,ba
5a
bond 3a 3b 5b
C1−C2 1.437(4) 1.440(3) 1.4661(3) 1.4636(3) 1.4655(16)
C2−C3 1.352(3) 1.355(2) 1.3416(3) 1.3482(3) 1.3565(16)
C3−C4 1.496(3) 1.497(3) 1.5190(3) 1.5180(3) 1.5235(17)
C1−O 1.268(3) 1.277(2) 1.2554(2) 1.2557(2) 1.2613(15)
O−B 1.569(3) 1.565(2) 1.5732(3) 1.5723(3) 1.5660(16)
B−C4 1.604(3) 1.603(3) 1.6183(3) 1.6148(3) 1.6136(17)
a5a has two molecules in the asymmetric unit.
Scheme 6. Reactions of B(C6F5)3 with Allenyl Esters 4.
Figure 4. Solid-state molecular structures of 5a (top, only one of the
two independent molecules is shown) and 5b (bottom): C, black; O,
red; B, yellow-green; F, pink. Hydrogen atoms are omitted for clarity.
Scheme 7. Reactions of B(C6F5)3 with Allenyl Ester 4c
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Mechanistically, we attribute the generation of the 1,2-
carboboration and cyclization products to two diﬀerent
potential activation modes: σ-activation (dative bond formation
between the carbonyl oxygen atom and boron) and π-activation
(Scheme 8). It is possible that a weak van der Waals interaction
between the borane and π-bond occurs prior to 1,2-addition, as
observed in FLP chemistry,11 although another possible
explanation would be the formation of a covalently bound
borate−carbocation intermediate. In the case of alkene−borane
π-activation of the allene moiety (IV) a vinyl borate compound
is formed (V). This reactivity is analogous to that observed in
transition-metal-catalyzed reactions.25 Although a pathway
involving the B(C6F5)3-mediated generation of a strong
Brønsted acid (H+) in the presence of water cannot be
excluded, we observe a small sharp peak at δ −15.8 ppm in the
in situ 11B NMR spectrum in the 1:1 reaction of allenyl ester 4c
and B(C6F5)3. This might be attributed to the generation of the
vinyl borate compound V (in the cyclization of propargyl
amides the corresponding vinyl borate compounds exhibited
very similar chemical shifts in the 11B NMR spectra δ ∼−16
ppm).8,23 In the case where water is present, hydrolysis of V
takes place releasing the γ-lactone 6 via protodeboronation of
the C−B bond and dealkylation of the oxygen atom.26 The
presence of water appears necessary to generate a driving force
for the cyclization event, as in its absence conversion to the
vinyl borate could not be observed. This suggests a reversible
cyclization process, which can only be trapped by the presence
of a suitable nucleophile which acts to dealkylate the oxygen
atom generating the B(C6F5)3-substituted lactone. Subsequent
protodeboronation regenerates B(C6F5)3 and yields the γ-
lactone.
The alternative bond activation process leading to the 1,2-
carboboration product is triggered by the σ-activation of the
carbonyl moiety. Here, adduct formation between the Lewis
acid and the ketone oxygen atom reduces the electron density
from the β-position of the allene moiety, generating a partial
positive charge while at the same time increasing the
nucleophilicity of the B−C6F5 bond (I and II). This facilitates
migration of the C6F5 group to the β-position of the allene,
yielding the dienyloxyborane III which undergoes a [1,5]-B
sigmatropic shift to give the products 3/5. The diastereose-
lective formation of the double bond in these reactions is
presumably due to the formation of a six-membered intra-
molecular chelate that dictates the geometry of the double
bond in the product. This mechanism is also in agreement with
the observed selectivity: while the allenyl ketones coordinate
more strongly to B(C6F5)3 and therefore strongly polarize the
allene moiety, the 1,2-carboboration mechanism overpowers
other reaction pathways. In contrast, the corresponding allenyl
esters form much weaker adducts;27 therefore, alternative
reaction pathways become accessible. In the absence of water
1,2-carboboration products 5 are formed, while in its presence
the cyclization pathway yielding 6 can dominate.
Theoretical Considerations. Two sets of representative
DFT calculations were undertaken to probe the activity of these
acceptor-substituted allenes with respect to (i) addition of a
Lewis acid/base pair and (ii) addition of the Lewis acid
followed by a subsequent C6F5 migration. In the ﬁrst instance
addition of B(C6F5)3 to the parent allenyl ketone 1a was
considered followed by addition of triphenylphosphine. In each
case the structures were fully optimized at the B3LYP/6-31G*
level of theory, followed by thermodynamic calculations based
on single-point B3LYP/6-311G*+ computations which were
ZPE corrected. Furthermore, a NBO analysis was carried out to
probe changes to the bonding scenario. These reveal that σ-
coordination of the Lewis acid to the allenyl ketone (Lewis
acid/base coordination) is thermodynamically favorable (ΔH =
−23 kJ/mol) and leads to an increase in partial charge on the
central carbon atom of the allene from +0.12 to +0.21 e.
Subsequent addition of PPh3 is also thermodynamically
favorable (ΔH = −55 kJ/mol). The geometric parameters for
the ﬁnal geometry-optimized structure are in good agreement
with experimental data. Similarly, studies were undertaken to
probe the activation of the allenyl ester MeCHC
CMeCO2Me (4d) by B(C6F5)3 followed by C6F5 migration.
These revealed that initial adduct formation was also favorable
by 12 kJ/mol and that C6F5-group migration was favored by
111 kJ/mol. Attempts to identify a concerted process in which
Figure 5. Solid-state structure of compound 6c: C, black; O, red; B,
yellow-green; F, pink. Hydrogen atoms are omitted for clarity.
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C6F5 migration occurred concomitantly with C−B bond
formation proved unsuccessful, suggesting a multistep migra-
tion process with one or more transient intermediates. An NBO
analysis of the coordination of the Lewis acid to the allenyl
ester (4d) revealed that while partial charge on the central
carbon center of the allene increased upon coordination (from
+0.13 to +0.16 e), this increase in partial positive charge was
much less pronounced (almost negligible) than that observed
with allenyl ketones (see above). This is in accordance with the
observations that the allenyl ketones undergo much more rapid
C6F5-group transfer than the corresponding allenyl esters (see
the Supporting Information).
■ CONCLUSIONS
Addition of a (frustrated) Lewis acid−base pair to acceptor-
substituted allenes (allenyl ketones or esters) occurs via O
coordination of the ketone to the Lewis acid with the associated
activation of the central allene carbon atom toward nucleophilic
attack by the phosphine. In the absence of a Lewis base two
reaction pathways need to be discriminated: σ-oxygen
activation vs π-allene activation. While in the case of the
strongly polarized and strongly coordinating allenyl ketones
exclusive σ-activation triggers a 1,2-carboboration mechanism,
allenyl esters can undergo alternative reaction pathways. In the
presence of water the formation of γ-lactone products could be
observed, which is reminiscent of reactivity typically eﬀected by
π-Lewis acidic transition metals. We should note that the 1,2-
carboboration products of the reactions with B(C6F5)3 generate
organoboron compounds, which might have applications in
organic synthesis. Future studies will aim at addressing their
reactivity toward organic electrophiles as well as investigating
the catalytic synthesis of γ-lactones using B(C6F5)3.
■ EXPERIMENTAL SECTION
General Experimental Considerations. With the exception of
the synthesis of starting materials, all reactions and manipulations were
carried out under an atmosphere of dry, O2-free nitrogen using
standard double-manifold techniques with a rotary oil pump. An
argon- or nitrogen-ﬁlled glovebox (MBRAUN) was used to
manipulate solids, including the storage of starting materials, room-
temperature reactions, product recovery, and sample preparation for
analysis. All solvents (toluene, CH2Cl2, pentane, hexane) were dried by
employing a Grubbs-type column system (Innovative Technology) or
an MB SPS-800 solvent puriﬁcation system and stored under a
nitrogen atmosphere. Deuterated solvents were distilled and/or dried
over molecular sieves before use. Chemicals were purchased from
commercial suppliers and used as received. 1H, 13C, 11B, and 19F NMR
spectra were recorded on Bruker Avance II 400, Bruker Avance 500,
Bruker Avance III 600, and JEOL 300 spectrometers. Chemical shifts
are expressed as parts per million (ppm, δ) downﬁeld of
tetramethylsilane (TMS) and are referenced to CDCl3 (7.26/77.16
ppm) and CD2Cl2 (5.32/53.80 ppm) as internal standards. NMR




11B). The description of signals include the following: s =
singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad.
All coupling constants are absolute values, and J values are expressed in
hertz (Hz). 13C NMR spectra were all measured as 1H-decoupled. IR
spectra were recorded using a Shimadzu IRAﬃnity-1 spectropho-
tometer, Elemental analysis was conducted by Mr. Stephen Boyer of
London Metropolitan University. Mass spectra were obtained in house
using a Waters LCT Premier/XE or a Waters GCT Premier
spectrometer and were calculated using 10B. All spectra were analyzed
assuming a ﬁrst-order approximation. For the synthesis of the allene
starting materials (1) and the reactions of 1 with phosphines along
with 1H, 11B, 13C, 19F, 31P, and 31P{1H} NMR spectra for all
compounds see the Supporting Information.
Synthesis of 2. General Procedure. PR3 (0.1 mmol, 1 equiv) in
CDCl3 (0.5 mL) was added to B(C6F5)3 (51 mg, 0.1 mmol, 1 equiv)
to give a pale yellow solution, which was then transferred to 1 (0.1
mmol, 1 equiv) to give a red solution. The mixture was transferred to
an NMR tube, and the 1H, 13C 11B, 19F, 31P and 31P{1H} NMR spectra
were measured. Multinuclear NMR reaction spectra for 2a were not
recorded due to the product precipitating out of solution upon
reaction; similarly, an in situ 13C NMR spectrum of 2c was not
recorded for the same reason.
Compound 2a. Yield: 58.3 mg, 88.9 μmol, 89%. IR (cm−1): νmax
3054, 2987, 2685, 2412, 2305, 1642, 1558, 1515, 1466, 1423, 1266,
1087, 980, 896, 747, 735, 706. HRMS ESI−: m/z calculated for [M −
H]− [C49H28BF15OP]
−, 958.1768; found, 958.1782.
Compound 2b. Yield: 65 mg, 66.7 μmol, 67%. Mp: 178−193 °C.
1H NMR (500 MHz, CDCl3, 298 K): 7.37−7.07 (m, 12H, phosphine
C−H), 7.37−7.07 (m, 4H, Ar−H), 5.40 (d, 3JHP = 53 Hz, 1H, C−H),
5.22 (d, 3JHP = 26 Hz, 1H, C−H), 4.34 (d, 3JHP = 11 Hz, 1H, CCH)
2.45 (s, br, 3H, Ar−CH3), 2.25 (s, br, 3H, phosphine CH3), 1.78 (s, br,
3H, phosphine CH3), 1.59 (s, br, 3H, phosphine CH3).
13C NMR
(126 MHz, CDCl3, 298 K): 165.2 (s), 151.5 (s), 148.9 (s), 146.9 (s),
138.4 (s), 137.5 (s), 134.9 (s), 133.6 (s), 132.2 (s), 130.9 (s), 129.7
(s), 127.7 (s), 93.7 (s), 22.6 (s), 21.5 (s). 11B NMR (160 MHz,
CDCl3, 298 K): −4.0 (s, br). 19F NMR (282 MHz, CDCl3, 298 K):
−132.7 (m, 2F, o-F), −161.1 (t, 3JFF = 20 Hz, 1F, p-F), −165.9 (m, 2F,
m-F). 31P NMR (202 MHz, CDCl3, 298 K): 22.9 (s, br).
31P{1H}
NMR (202 MHz, CDCl3, 298 K): 23.0 (s). IR (cm
−1): νmax 3055,
2987, 2925, 2853, 2687, 2412, 2306, 1643, 1586, 1558, 1513, 1465,
1423, 1390, 1373, 1266, 1202, 1137, 1114, 1087, 997, 980, 927, 897,
836, 809, 742, 707. HRMS ESI−: m/z calculated for [M − H]−
[C50H30BF15OP]
−, 972.1924; found, 972.1971. Anal. Calcd for
C50H31BF15OP: C, 61.62; H, 3.21. Found: C, 61.68; H, 3.14.
Compound 2c. Yield: 47 mg, 47.4 μmol, 47%. Mp: 176−187 °C.
1H NMR (500 MHz, CDCl3, 298 K): 8.28−7.14 (m, 12H, phosphine
C−H), 7.52 (d, 3JHH = 8.7 Hz, 2H, o-H), 6.89 (d, 3JHH = 8.7 Hz, 2H,
m-H), 5.54 (d, 3JHP = 52 Hz, 1H, C−H), 5.35 (d, 3JHP = 26 Hz, 1H,
C−H), 4.42 (d, 3JHP = 11 Hz, 1H, CC−H), 3.79 (s, 3H, Ar−
OCH3), 2.45 (s, br, 3H, phosphine CH3), 1.85 (s, br, 3H, phosphine
CH3), 1.65 (s, br, 3H, phosphine CH3).
11B NMR (160 MHz, CDCl3,
298 K): −4.0 (s, br). 19F NMR (282 MHz, CDCl3, 298 K): −132.7
(m, 2F, o-F), −161.1 (t, 3JFF = 21 Hz, 1F, p-F), −165.9 (m, 2F, m-F).
31P NMR (202 MHz, CDCl3, 298 K): 22.7 (s, br).
31P{1H} NMR (202
MHz, CDCl3, 298 K): 22.8 (s). IR (cm
−1): νmax 3055, 2988, 2931,
2856, 2687, 2524, 2411, 2306, 1713, 1643, 1610, 1587, 1557, 1513,
1465, 1423, 1390, 1373, 1267, 1175, 1138, 1088, 1032, 980, 925, 908,
897, 842, 808, 756, 724, 706. HRMS ESI−: m/z calculated for [M −
H]− [C50H30BF15O2P]
−, 988.1873; found, 988.1891. Anal. Calcd for
C50H31BF15O2P·CDCl3: C, 55.14; H, 2.99. Found: C, 55.07; H, 2.26.
Compound 2d. Yield: 98 mg, 98.5 μmol, 99%. Mp: 186−194 °C.
1H NMR (500 MHz, CDCl3, 298 K): 8.15−7.17 (m, 12H, phosphine
C−H), 7.53 (d, 3JHH = 8.5 Hz, o-H), 7.34 (d, 3JHH = 8.5 Hz, m-H),
5.52 (d, 3JHP = 52 Hz, 1H, C−H), 5.38 (d, 3JHP = 25 Hz, 1H, C−H),
4.48 (d, 3JHP = 10 Hz, 1H, C−H), 2.44 (s, br, 3H, phosphine CH3),
1.83 (s, br, 3H, phosphine CH3), 1.66 (s, br, 3H, phosphine CH3).
13C
NMR (126 MHz, CDCl3, 298 K): 163.8 (m), 149.1 (s), 147.2 (s),
143.9 (s), 143.2 (s), 143.2 (s), 139.0 (s), 137.8 (s), 135.3 (s), 134.7
(s), 134.0 (s), 133.5 (s), 130.0 (s), 129.7 (s), 129.5 (s), 129.3 (s),
126.6 (s), 113.5 (s), 94.6 (m), 26.0 (s), 22.8 (s, br), 21.5 (s), 19.4 (s).
11B NMR (160 MHz, CDCl3, 298 K): −3.9 (s, br). 19F NMR (282
MHz, CDCl3, 298 K): −132.9 (m, 2F, o-F), −160.8 (t, 3JFF = 20 Hz,
1F, p-F), −165.6 (m, 2F, m-F). 31P NMR (202 MHz, CDCl3, 298 K):
23.0 (s, br). 31P{1H} NMR (202 MHz, CDCl3, 298 K): 23.1 (s). IR
(cm−1): νmax 3055, 2987, 2685, 2412, 2308, 1644, 1585, 1556, 1515,
1488, 1466, 1422, 1390, 1371, 1296, 1267, 1202, 1171, 1136, 1122,
1088, 1032, 1016, 996, 979, 926, 910, 898, 844, 808, 750, 729, 706.
HRMS ESI−: m/z calculated for [M − H]− [C49H27BClF15OP]−,
992.1378; found, 992.1411.
Compound 2e. Yield: 100 mg, 88.1 μmol, 88%. Mp: 98−115 °C.
1H NMR (500 MHz, CDCl3, 298 K): 7.59−6.84 (m, 12H, phosphine
C−H), 7.59−6.84 (m, 4H, Ar−H), 7.59−6.84 (m, br, 2H, furan C−
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H), 5.87 (d, 3JHP = 50 Hz, 1H, C−H), 5.63 (d, 3JHP = 23 Hz, 1H, C−
H), 4.36 (d, 3JHP = 7.4 Hz, 1H, CC−H), 2.30 (s, 3H, phosphine
CH3), 1.79 (s, 3H, phosphine CH3), 1.58 (s, 3H, phosphine CH3).
13C
NMR (126 MHz, CDCl3, 298 K): 151.5 (s), 150.7 (m), 148.3 (s),
147.7 (s), 145.8 (s), 138.6 (s), 136.5 (s), 133.9 (s), 129.8 (s), 128.1
(s), 127.4 (s), 126.8 (s), 125.3 (s), 114.1 (s), 112.2 (s), 95.2 (m), 21.6
(s), 20.0 (m). 11B NMR (160 MHz, CDCl3, 298 K): −3.6 (s, br). 19F
NMR (282 MHz, CDCl3, 298 K): −132.9 (m, 2F, o-F), −161.2 (t, 3JFF
= 21 Hz, 1F, p-F), −165.7 (m, 2F, m-F). 31P NMR (202 MHz, CDCl3,
298 K): 23.7 (s), 19.7 (s, br). 31P{1H} NMR (202 MHz, CDCl3, 298
K): 23.6 (s), 19.7 (s, br). IR (cm−1): νmax 3055, 2988, 2686, 2522,
2412, 2306, 1712, 1645, 1593, 1566, 1555, 1514, 1466, 1424, 1368,
1265, 1223, 1170, 1137, 1087, 1025, 978, 897, 808, 753, 723, 705.
HRMS ESI−: m/z calculated for [M − H]− [C53H29BClF15O2P]−,
1058.1484; found, 1058.1536.
Compound 2f. Yield: 55 mg, 54.9 μmol, 55%. Mp: 151−164 °C. 1H
NMR (500 MHz, CDCl3, 298 K): 7.71−7.48 (m, 3H, phosphine C−
H), 7.39 (t, br, 3JHH = 8.1 Hz, 3H, phosphine C−H), 7.34 (d, 3JHH =
8.2 Hz, 2H, o-H), 7.16 (m, 3H, phosphine C−H), 7.05 (m, 3H,
phosphine C−H), 6.74 (d, 3JHH = 8.2 Hz, 2H, m-H), 5.63 (d, 3JHP = 53
Hz, 1H,C−H), 5.06 (d, 3JHP = 25 Hz, 1H,C−H), 4.45 (d, 3JHP =
9.8 Hz, 1H, C−H), 3.67 (s, 3H, OCH3). 13C NMR (126 MHz,
CDCl3, 298 K): 166.0 (m), 163.8 (m), 161.9 (m), 160.0 (s), 148.6 (s),
139.6 (s), 137.5 (m), 135.4 (m), 132.9 (s), 132.6 (m), 131.1 (s), 129.7
(s), 129.7 (s), 129.4 (s), 123.1 (m), 120.6 (m), 119.4 (s), 118.8 (s),
114.0 (s), 92.3 (m), 55.1 (s). 11B NMR (160 MHz, CDCl3, 298 K):
−3.8 (s, br). 19F NMR (282 MHz, CDCl3, 298 K): −105.5 (m, 1F,
phosphine), −133.2 (d, 3JFF = 22 Hz, 2F, o-F), 160.8 (t, 3JFF = 21 Hz,
1F, p-F), 165.6 (t, 3JFF = 21 Hz, 2F, m-F).
31P NMR (202 MHz,
CDCl3, 298 K): 22.6 (s).
31P{1H} NMR (202 MHz, CDCl3, 298 K):
22.7 (s). IR (cm−1): νmax 3055, 2987, 2686, 2411, 2306, 1644, 1610,
1585, 1556, 1514, 1480, 1465, 1423, 1270, 1262, 1237, 1175, 1098,
1090, 1033, 999, 981, 925, 897, 844, 794, 757, 723, 706. HRMS AP+:
m/z calculated for [M]+ [C47H22BF18O2P]
+, 1002.1163; found,
1002.1166. Anal. Calcd for C47H22BF18O2P: C, 56.31; H, 2.21.
Found: C, 56.27; H, 2.18.
Compound 2g. Yield: 93 mg, 92.4 μmol, 92%. Mp: 119−141 °C.
1H NMR (500 MHz, CDCl3, 298 K): 7.54−7.02 (m, 12H, phosphine
C−H) 7.54−7.02 (m, 4H, Ar−H), 5.62 (d, 3JHH = 53 Hz, 1H, C−
H), 5.11 (d, 3JHH = 25 Hz, 1H,C−H), 4.52 (d, 3JHH = 9.4 Hz, 1H,CH). 13C NMR (126 MHz, CDCl3, 298 K): 165.3 (m), 164.4 (m),
162.3 (m), 149.1 (m), 147.2 (m), 140.2 (m), 137.9 (m), 137.7 (s),
135.8 (m), 135.2 (s), 134.2 (m), 133.1 (m), 130.8 (m), 130.0 (m),
129.4 (m), 127.9 (s), 127.3 (s), 123.8 (m), 121.2 (m), 119.7 (m),
119.0 (m), 117.0 (m), 93.6 (m). 11B NMR (160 MHz, CDCl3, 298 K):
−3.8 (s, br). 19F NMR (282 MHz, CDCl3, 298 K): −105.2 (m, 1F,
P(m-FC6H4)3), −133.3 (m, 2F, o-F), −160.4 (t, 3JFF = 20.3 Hz, 1F, p-
F), −165.4 (m, 2F, m-F). 31P NMR (202 MHz, CDCl3, 298 K): 22.9
(s, br). 31P{1H} NMR (202 MHz, CDCl3, 298 K): 22.8 (s). IR
(cm−1): νmax 3055, 2988, 2964, 2932, 2874, 2861, 2686, 2411, 2307,
1720, 1682, 1644, 1585, 1556, 1514, 1480, 1465, 1424, 1370, 1267,
1235, 1100, 1056, 1015, 998, 979, 966, 926, 898, 843, 794, 752, 731,
707. HRMS ESI−: m/z calculated for [M − H]− [C46H18BClF18OP]−,
1004.0626; found, 1004.0672.
Compound 2h. Yield: 70 mg, 67.4 μmol, 67%. Mp: 110−122 °C.
1H NMR (500 MHz, CDCl3, 298 K): 7.32 (d,
3JHH = 8.4 Hz, 2H, Ar o-
H), 7.24 (m, 6H, phosphine m-H), 6.89 (dd, 3JHH = 8.8 Hz,
4JHH = 2.5
Hz, 6H, phosphine o-H), 6.70 (d, 3JHH = 8.7 Hz, 2H, Ar m-H), 5.47 (d,
3JHP = 50 Hz, 1H,C−H), 5.00 (d, 3JHP = 24 Hz, 1H,C−H), 4.47
(d, 3JHP = 9.0 Hz, 1H, CH), 3.77 (s, 9H, phosphine CH3), 3.66 (s,
3H, OCH3).
13C NMR (126 MHz, CDCl3, 298 K): 164.8 (s), 164.11
(m), 159.9 (s), 149.0 (s, br), 147.1 (s, br), 137.7 (m), 135.8 (m),
132.0 (s), 131.7 (s), 130.8 (s), 129.9 (s), 115.8 (m), 113.9 (s), 109.2
(s), 108.4 (s), 94.0 (m), 55.7 (s), 55.3 (s). 11B NMR (160 MHz,
CDCl3, 298 K): −3.8 (s, br). 19F NMR (282 MHz, CDCl3, 298 K):
−133.0 (m, 2F, o-F), −161.2 (t, 3JFF = 21 Hz, 1F, p-F), −165.8 (t, 3JFF
= 21 Hz, 2F, m-F). 31P NMR (202 MHz, CDCl3, 298 K): 21.8 (s, br).
31P{1H} NMR (202 MHz, CDCl3, 298 K): 21.7 (s). IR (cm
−1): νmax
3055, 2988, 2845, 2687, 2410, 2307, 1713, 1643, 1596, 1568, 1513,
1505, 1464, 1443, 1423, 1364, 1297, 1267, 1184, 1170, 1112, 1084,
1026, 966, 897, 834, 805, 753, 728, 705. HRMS ESI−: m/z calculated
for [M − H]− [C50H30BF15O5P]−, 1036.1721; found, 1036.1725.
Compound 2i. Yield: 100 mg, 95.9 μmol, 96%. Mp: 87−99 °C. 1H
NMR (500 MHz, CDCl3, 298 K): 7.30 (d,
3JHH = 8.8 Hz, 2H, Ar o-H),
7.24−7.20 (m, 6H, phosphine C−H), 7.12 (d, 3JHH = 8.4 Hz, 2H, Ar
m-H), 6.92−6.91 (m, 6H, phosphine C−H), 5.47 (d, 3JHP = 49 Hz,
1H,C−H), 5.06 (d, 3JHP = 23 Hz, 1H,C−H), 4.54 (d, 3JHP = 8.6
Hz, 1H, CH), 3.78 (s, 9H, phosphine CH3). 13C NMR (126 MHz,
CDCl3, 298 K): 164.6 (m), 148.8 (m), 146.7 (m), 136.0 (m), 135.5
(m), 129.8 (s), 129.1 (s), 128.9 (s), 128.5 (s), 128.1 (s), 125.2 (s),
116.6 (m), 115.7 (m), 108.6 (m), 107.9 (m), 55.6 (m), 31.5 (s), 22.6
(s), 21.3 (s), 14.0 (s). 11B NMR (160 MHz, CDCl3, 298 K): −3.8 (s,
br). 19F NMR (282 MHz, CDCl3, 298 K): −133.1 (m, 2F, o-F),
−160.9 (t, 3JFF = 20.7 Hz, 1F, p-F), −165.6 (m, 2F, m-F). 31P NMR
(202 MHz, CDCl3, 298 K): 21.6 (s).
31P{1H} NMR (202 MHz,
CDCl3, 298 K): 21.7 (s). IR (cm
−1): νmax 3054, 2988, 2846, 2685,
2309, 1713, 1644, 1594, 1567, 1514, 1504, 1465, 1422, 1366, 1300,
1265, 1223, 1184, 1113, 1088, 1024, 979, 965, 896, 835, 806, 739, 706.
HRMS ESI−: m/z calculated for [M − H]− [C49H27BClF15O4P]−,
1040.1225; found, 1040.1245.
Compound 2j. Yield: 62 mg, 62.6 μmol, 63%. Mp: 168−181 °C. 1H
NMR (500 MHz, CDCl3, 298 K): 7.39−7.34 (m, 9H, phosphine C−
H), 7.39−7.34 (m, 2H, Ar o-H) 6.89 (m, 6H, phosphine C−H), 6.80
(d, 3JHH = 8.8 Hz, 2H, Ar m-H), 5.58 (d,
3JHP = 47 Hz, 1H,C−H),
5.19 (d, 3JHP = 20 Hz, 1H, C−H), 4.87 (d, 3JHP = 8.3 Hz, 1H, 
CH), 3.78 (s, 3H, OCH3), 3.20 (d,
3JHP = 13 Hz, 6H, phosphine
CH2).
13C NMR (126 MHz, CDCl3, 298 K): 196.9 (s), 164.5 (m),
149.1 (s, br) 147.2 (s, br) 137.9 (s, br), 137.3 (s), 135.9 (m), 134.7
(s), 133.3 (s), 130.3 (m), 129.2 (m), 128.7 (m), 126.1 (s), 91.3 (m),
28.6 (m), 26.0 (m). 11B NMR (160 MHz, CDCl3, 298 K): −3.57 (s,
br). 19F NMR (282 MHz, CDCl3, 298 K): −132.9 (m, 2F, o-F),
−160.3 (t, 3JFF = 21.1, 1F, p-F), 165.1 (m, 2F, m-F). 31P NMR (202
MHz, CDCl3, 298 K): 25.1 (m).
31P{1H} NMR (202 MHz, CDCl3,
298 K): 25.0 (s). IR (cm−1): νmax 3055, 2987, 2961, 2926, 2855, 2687,
2411, 2359, 2308, 1716, 1643, 1609, 1588, 1565, 1514, 1498, 1465,
1423, 1365, 1266, 1175, 1088, 1032, 980, 925, 896, 865, 845, 808, 751,
730, 706. HRMS ESI− : m/z calculated for [M − H]−
[C50H30BF15O2P]
−, 988.1873; found, 988.1896. Anal. Calcd for
C50H31BF15O2P: C, 60.63; H, 3.15. Found: C, 60.48; H, 2.94.
Compound 2k. Yield: 87 mg, 87.4 μmol, 87%. Mp: 91−103 °C. 1H
NMR (500 MHz, CDCl3, 298 K): 7.29−7.21 (m, 9H, phosphine C−
H), 7.29−7.21 (m, 2H, Ar o-H), 7.14 (m, 2H, Ar m-H), 6.77 (m, 6H,
phosphine C−H), 5.42 (d, 3JHP = 47 Hz, 1H, C−H), 5.09 (d, 3JHP = 20
Hz, 1, C−H), 4.8 (d, 3JHP = 8.1 Hz, 1H,CH), 3.13 (d, 3JHP = 13 Hz,
6H, phosphine CH2).
13C NMR (126 MHz, CDCl3, 298 K): 186.7 (s),
167.5 (s), 155.9 (s), 148.3 (s), 139.8 (s), 138.1 (s), 130.3 (m), 129.6
(m), 128.8 (m), 126.2 (s), 93.6 (s), 34.5 (m), 22.4 (m). 11B NMR
(160 MHz, CDCl3, 298 K): −3.5 (s, br). 19F NMR (282 MHz, CDCl3,
298 K): −132.9 (m, 2F, o-F), −160.1 (t, 3JFF = 20.6 Hz, 1F, p-F),
−164.9 (m, 2F, m-F). 31P NMR (202 MHz, CDCl3, 298 K): 25.4 (m).
31P{1H} NMR (202 MHz, CDCl3, 298 K): 25.2 (s). IR (cm
−1): νmax
3055, 2987, 2927, 2854, 2687, 2412, 2361, 2307, 1714, 1678, 1645,
1589, 1515, 1464, 1423, 1364, 1266, 1222, 1088, 978, 964, 897, 751,
728, 707. HRMS ESI− : m/z calculated for [M − H]−
[C49H27BClF15OP]
−, 992.1378; found, 992.1357. Anal. Calcd for
C49H28BClF15OP: C, 59.15; H, 2.84. Found: C, 59.02; H, 2.86.
Alternative Synthesis of 2c. B(C6F5)3 (103 mg, 0.2 mmol), P(o-
tol)3 (60 mg, 0.2 mmol), and 1-(4-methoxyphenyl)buta-2,3-dien-1-
one 1c (36 mg, 0.2 mmol) were mixed in toluene (2 mL), giving a
yellow solution. The reaction mixture was left to stand at room
temperature for 24 h. Removal of the solvent aﬀorded an orange oil.
Washing with hexane (3 × 2 mL) yielded the product 2c (159 mg,
0.16 mmol, 80%). The addition of hot hexane (ca. 2 mL) and a few
drops of hot toluene to give a clear solution gave, upon cooling and
prolonged storage (3−4 days), a few colorless needle-shaped crystals
of 2c.
Synthesis of Compounds 3a−e. General Procedure. B(C6F5)3
(51 mg, 0.1 mmol, 1 equiv) in CDCl3 (0.5 mL) was added to 3 (0.1
Organometallics Article
DOI: 10.1021/acs.organomet.5b00546
Organometallics 2015, 34, 4127−4137
4134
mmol, 1 equiv), the mixture was transferred to an NMR tube, and the
1H, 11B, 13C, and 19F NMR spectra were measured.
Compound 3a. Yield: 26 mg, 39.6 μmol, 40%. Mp: 48−51 °C. 1H
NMR (500 MHz, CDCl3, 298 K): 8.26 (d,
3JHH = 7.7 Hz, 2H, o-H),
7.88 (t, 3JHH = 7.6 Hz, 1H, p-H), 7.67 (t,
3JHH = 7.7 Hz, 2H, m-H),
7.33 (s, C−H), 2.74 (s, 2H, CH2). 13C NMR (126 MHz, CDCl3, 298
K): 192.6 (s), 169.1 (s), 148.9 (m), 147.0 (m), 146.3 (m), 143.2 (m),
141.4 (m), 141.0 (m), 138.6 (s), 138.3 (m), 137.3 (m), 136.4 (m),
132.9 (s), 131.9 (s), 130.1 (s), 121.2 (s), 116.0 (m), 27.2 (m). 11B
NMR (160 MHz, CDCl3, 298 K): 2.7 (s, br).
19F NMR (282 MHz,
CDCl3, 298 K): −135.1 (m, 4F, o-F), −138.2 (m, 2F, o-F), −149.1 (t,
3JFF = 20.5 Hz, 1F, p-F), −157.6 (t, 3JFF = 20.7 Hz, 2F, p-F), −159.7
(m, 2F, m-F), −163.6 (m, 4F, m-F). IR (cm−1): νmax 3055, 2988, 2689,
2365, 2307, 1736, 1719, 1651, 1520, 1473, 1422, 1270, 1262, 1096,
982, 897, 759, 721, 708. HRMS ESI−: m/z calculated for [M − H]−
[C28H7BF15O]
−: ,654.0387; found, 654.0378.
Compound 3b. Yield: 64 mg, 95.5 μmol, 96%. Mp: 48−52 °C. 1H
NMR (500 MHz, CDCl3, 298 K): 8.19 (d,
3JHH = 8.4 Hz, 2H, o-H),
7.46 (d, 3JHH = 8.4 Hz, 2H, m-H), 7.29 (s, C−H), 2.71 (s, 2H, CH2),
2.54 (s, 3H, CH3).
13C NMR (126 MHz, CDCl3, 298 K): 191.8 (s),
168.1 (s), 151.7 (s), 149.2 (m), 147.4 (s), 145.5 (m), 143.5 (m), 141.3
(m), 138.7 (m), 137.7 (m), 136.7 (m), 132.4 (s), 131.2 (s), 130.6 (s),
121.4 (s), 116.4 (m), 22.8 (s). 11B NMR (160 MHz, CDCl3, 298 K):
2.2 (s, br). 19F NMR (282 MHz, CDCl3, 298 K): −135.1 (m, 4F, o-F),
−138.5 (m, 2F, o-F), −149.6 (t, 3JFF = 20.1 Hz, 1F, p-F), −157.8 (t,
3JFF = 20.6 Hz, 2F, p-F), −159.9 (m, 2F, m-F), −163.7 (m, 4F, m-F).
IR (cm−1): νmax 3055, 2983, 2686, 2411, 2360, 2343, 2307, 1714, 1650,
1606, 1520, 1486, 1422, 1364, 1319, 1268, 1264, 1223, 1184, 1093,
980, 896, 754, 726, 704. HRMS ESI−: m/z calculated for [M − H]−
[C29H9BF15O]
−, 668.0543; found, 668.0535. Anal. Calcd for
C29H10BF15O: C: 51.97, H: 1.50. Found: C: 51.86, H: 1.46.
Compound 3c. Yield: 68 mg, 99.1 μmol, 99%. Mp: 64−71 °C. 1H
NMR (500 MHz, CDCl3, 298 K): 8.30 (d,
3JHH = 8.6 Hz, 2H, o-H),
7.23 (s, C−H), 7.11 (d, 3JHH = 8.6 Hz, 2H, m-H), 4.00 (s, 3H, CH3),
2.66 (s, 2H, CH2).
13C NMR (126 MHz, CDCl3, 298 K): 189.0 (s),
168.8 (s), 165.8 (s), 150.0 (m), 147.0 (m), 145.1 (m), 143.2 (m),
140.7 (m), 138.9 (m), 138.2 (m), 137.2 (m), 136.3 (m), 135.2 (s),
125.5 (s), 120.9 (s), 116.4 (m), 115.8 (s), 56.4 (s), 26.9 (s, br). 11B
NMR (160 MHz, CDCl3, 298 K): 1.7 (s, br).
19F NMR (282 MHz,
CDCl3, 298 K): −135.2 (m, 4F, o-F), −138.9 (m, 2F, o-F), −150.3 (t,
3JFF = 20.9 Hz, 1F, p-F), −158.2 (t, 3JFF = 21.0 Hz, 2F, p-F), −160.2
(m, 2F, m-F), −163.9 (m, 4F, m-F). IR (cm−1): νmax 3056, 2989, 2687,
2413, 2361, 2308, 1713, 1649, 1593, 1572, 1518, 1496, 1465, 1427,
1384, 1271, 1264, 1178, 1095, 1050, 1019, 993, 978, 922, 897, 845,
758, 722, 706. HRMS ESI−: m/z calculated for [M − H]−
[C29H9BF15O2]
−, 684.0605; found, 684.0624.
Compound 3d. Yield: 58 mg, 84.0 μmol, 84%. Mp: 61−66 °C. 1H
NMR (500 MHz, CDCl3, 298 K): 8.22 (d,
3JHH = 8.5 Hz, 2H, o-H),
7.64 (d, 3JHH = 8.5 Hz, 2H, m-H), 7.28 (s, 1H, C−H), 2.75 (s, 2H,
CH2).
13C NMR (126 MHz, CDCl3, 298 K): 191.4 (s), 170.1 (s),
149.0 (m), 147.0 (m), 146.1 (s), 145.3 (m), 143.3 (m), 141.0 (m),
139.4 (m), 138.4 (m), 137.3 (m), 136.3 (m), 133.0 (s), 131.2 (s),
130.6 (s), 120.8 (s), 115.9 (m), 114.3 (s), 76.2 (s), 27.3 (s), 24.8 (s),
21.1 (m). 11B NMR (160 MHz, CDCl3, 298 K): 2.1 (s, br).
19F NMR
(282 MHz, CDCl3, 298 K): −135.2 (m, 4F, o-F), −138.0 (m, 2F, o-F),
−148.7 (t, 3JFF = 21.1 Hz, 1F, p-F), −157.4 (t, 3JFF = 20.7 Hz, 2F, p-F),
−159.6 (m, 2F, m-F), −163.5 (m, 4F, m-F). IR (cm−1): νmax 3055,
2988, 2686, 2362, 2343, 2307, 1712, 1669, 1651, 1520, 1484, 1423,
1363, 1320, 1266, 1223, 1093, 980, 896, 749 732, 706. HRMS ESI−:
m/z calculated for [M − H]− [C28H6BClF15O]−, 687.9997; found,
687.9984.
Compound 3e. Yield: 46 mg, 60.8 μmol, 61%. Mp: 58−63 °C. 1H
NMR (500 MHz, CDCl3, 298 K): 8.04 (s, br, 1H, C−H), 7.81 (m, 1H,
C−H), 7.47 (m, 2H, Ar−H), 7.36 (m, 2H, Ar−H), 7.16 (s, 1H, C−
H), 2.60 (s, 2H, CH2).
13C NMR (126 MHz, CDCl3, 298 K): 176.1 (s,
br), 166.5 (s, br), 161.9 (s, br), 149.0 (m), 147.0 (m), 146.2 (m),
143.3 (m), 140.9 (m), 138.4 (m), 136.2 (m), 134.40 (s), 133.0 (s),
132.60 (s), 132.3 (s), 132.11 (s), 131.7 (s), 130.6 (s), 129.8 (s), 127.7
(s, br), 126.6 (s), 120.5 (s), 117.1 (s, br), 116.2 (m), 27.3 (m), 21.4
(s), 20.5 (s). 11B NMR (160 MHz, CDCl3, 298 K): 1.9 (s, br).
19F
NMR (282 MHz, CDCl3, 298 K): −135.1 (m, 4F, o-F), −138.3 (m,
2F, o-F), −149.9 (t, 3JFF = 21 Hz, 1F, p-F), −158.1 (t, 3JFF = 21 Hz, 2F,
p-F), −160.1 (m, 2F, m-F), −163.9 (m, 4F, m-F). IR (cm−1): νmax
3055, 2987, 2686, 2411, 2361, 2343, 2307, 1714, 1651, 1519, 1493,
1482, 1422, 1365, 1320, 1266, 1186, 1093, 1029, 982, 897, 752, 728,
706. Anal. Calcd for C32H9BClF15O2: C, 50.80; H, 1.20. Found: C,
50.74; H, 1.12.
Synthesis of 5a. B(C6F5)3 (103 mg, 0.2 mmol) was dissolved in
toluene (1 mL) and was added to ethyl 2,5-dimethylhexa-2,3-dienoate
(4a; 34 mg, 0.2 mmol) in toluene (1 mL). The reaction mixture was
left to stand at room temperature for 24 h, giving an orange solution.
Removal of the solvent aﬀorded a dark orange oil. Addition of hexane
(2 mL) and a small amount of DCM (ca. 0.5 mL to solubilize the oil)
followed by slow evaporation of the solvent aﬀorded colorless crystals
of the product. The remaining solution was decanted oﬀ and the solid
product washed with pentane (3 × 2 mL) and dried in vacuo to give
the pure product (36.3 mg, 27%, 0.05 mmol). 11B NMR (128 MHz,
CDCl3, 298 K): 4.2 (s, br).
Synthesis of 5b. B(C6F5)3 (103 mg, 0.2 mmol) was dissolved in
toluene (1 mL) and was added to ethyl 2-methyl-5-phenylpenta-2,3-
dienoate (4b; 43 mg, 0.2 mmol) in toluene (1 mL), giving a yellow
solution upon addition. The reaction mixture was left to stand at room
temperature for 24 h. Removal of the solvent aﬀorded a dark orange
oil. Addition of hexane (2 mL) and a small amount of toluene (ca. 0.5
mL to solubilize the oil) followed by slow evaporation of the solvent
aﬀorded colorless crystals of the product. The remaining solution was
decanted oﬀ and the solid product washed with pentane (3 × 2 mL)
and dried in vacuo to give the pure product (13.7 mg, 9%, 0.02 mmol).
1H NMR (400 MHz, C6D6, 298 K): 7.08−7.07 (m, 3H, o-H and p-H),
6.95 (d, 3JHH = 6.6 Hz, 2H, m-H), 4.68 and 4.43 (m, 2H, CH2
diastereotopic), 3.08 and 2.65 (m, 2H, CH2 diastereotopic), 1.78 (d,
4JHH = 2 Hz, 3H, CH3), 1.51 (t,
3JHH = 7.1 Hz, 3H, CH3), 0.88 (t,
3JHH
= 7.1 Hz, 1H, CH). 11B NMR (128 MHz, C6D6, 298 K): 4.5 (s, br).
19F NMR (282 MHz, C6D6, 298 K): −132.9 (m, 2F, o-F), −133.2 (m,
1F, o-F), −137.5 (br s, 2F, o-F), −139.3 (m, 1F, o-F), −152.2 (t, 3JFF =
21 Hz, 1F, p-F), −157.2 (t, 3JFF = 21 Hz, 1F, p-F), −157.8 (t, 3JFF = 20
Hz, 1F, p-F), −160.4 (m, 1F, m-F), −161.5 (m, 1F, m-F), −163.3 (m,
2F, m-F), −163.6 (m, 2F, m-F).
Synthesis of 6. B(C6F5)3 (102 mg, 0.2 mmol) was dissolved in
toluene (2 mL) and added to ethyl 2,4-dimethylpenta-2,3-dienoate
(4c; 31 mg, 0.2 mmol) to give a brown solution. After the addition of
1 equiv of H2O the reaction mixture was left at room temperature for
72 h. Slow evaporation of the solvent gave large brown crystals that
were suitable for X-ray diﬀraction. The remaining solid was washed
with hexane (3 × 2 mL) and dried in vacuo to give the pure product
(72 mg, 0.12 mmol, 56%). 1H NMR (500 MHz, CDCl3, 298 K): 7.42
(s, 1H, CH), 2.03 (s, 3H, CH3), 1.43 (s, 6H, (CH3)2). 13C NMR
(126 MHz, CDCl3, 298 K): 160.9 (s), 148.8 (s), 146.8 (s), 138.9 (s),
137.8 (s), 135.8 (s), 128.7 (s), 23.7 (s), 17.0 (s), 9.6 (s). 11B NMR
(160 MHz, CDCl3, 298 K): 40.4 (s, br), 26.2 (s, br), 1.1 (s, br, B−O
adduct), −3.6 (s, br). 19F NMR (282 MHz, CDCl3, 298 K): −134.7
(d, 3JFF = 21 Hz, 2F, o-F), −157.3 (t, 3JFF = 21 Hz, 1F, p-F), −164.2 (t,
3JFF = 21 Hz, 2F, m-F). HRMS ESI
+: m/z calculated for [M −
B(C6F5)3]
+ [C7H10O2]
+, 126.0681; found, 126.0683.
Crystallographic Studies. Crystallographic studies of compounds
2, 3, and 6 were undertaken on single crystals mounted in Paratone
and studied on an Agilent SuperNova dual four-circle diﬀractometer
using monochromatic Cu Kα (1.54184 Å) or Mo Kα (0.71073 Å)
radiation and a CCD detector. Measurements were typically made at
150(1) K with temperatures maintained using an Oxford cryostream.
Data were collected and integrated and data corrected for absorption
using a numerical absorption correction based on Gaussian integration
over a multifaceted crystal model within CrysAlisPro.28 The structures
were solved by direct methods and reﬁned against F2 within SHELXL-
2013.29 For compounds 5, intensity data sets were collected at low
temperature with a Bruker AXS Smart 1000 CCD diﬀractometer using
a sealed X-ray tube and graphite monochromator. Data sets for 5 were
corrected for air and detector absorption and Lorentz and polarization
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eﬀects;30 absorption by the crystal was treated with a semiempirical
multiscan method.31,32 The structures were solved by direct methods
with dual-space recycling33 (compound 5a) or by intrinsic phasing34
(compound 5b) and reﬁned by full-matrix least-squares methods based
on F2 against all unique reﬂections.35 The crystals of 5a were
pseudomerohedrally twinned (twin fractions 0.61:0.39); reﬁnement
was against all reﬂections involving both twin domains. All non-
hydrogen atoms were given anisotropic displacement parameters. The
positions of most hydrogen atoms (except those of the methyl groups)
were taken from diﬀerence Fourier syntheses and reﬁned. A summary
of crystallographic data are available as Supporting Information, and
the structures have been deposited with the Cambridge Structural
Database (CCDC deposition numbers 1062326−1062327 and
1062523−1062531).
Computational Studies. DFT calculations were carried out using
Jaguar v.8.7.36 and visualized within Maestro 10.1. All structures were
geometry optimized at the B3LYP/6-31G*+ level followed by
subsequent thermodynamic single-point energy calculations at the
triple-ζ B3LYP/6-311G*+ level and a zero point energy correction
made. Determination of partial charges and bond orders were made
using the NBO approach.37
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